The drug responsible for this is the dipeptidyl peptidase-4 inhibitor. People with type 2 diabetes have a hard time controlling their blood sugar levels as their insulin, used by the body for blood sugar management, is a point of dysfunction. Dipeptidyl peptidase-4 inhibitors, or gliptins, help type 2 diabetes patients to control the excessive flow of blood sugar continuously. The study, conducted on 282 individuals of 76 years average age, and 70 people were diabetic and were recorded under dipeptidyl peptidase-4 inhibitors takers. The other people studied were 71 individuals with type 2 diabetes without dipeptidyl peptidase-4 drugs and another 141 participants were not diagnosed with diabetes.

Source: dna August 17, 2021 06:22 UTC